Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticals
Experts answer questions with in-depth advice on the current clinical landscape and how new therapies and guidance might impact regional clinical practice. Useful tips below will show how to navigate the activity.
- Describe the underlying rationale and mechanism of action for radiopharmaceuticals in adult oncology
- Recall the different types of radiopharmaceuticals (approved and in clinical development), and their specific properties
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!